Navigation Links
Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/13/2008

passcode 72272011. A replay of this call will be available until February 27, 2008 by phone at 1-888-286-8010 (U.S.), or 1-617-801-6888 (international), using the passcode 23908777.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. For further information see http://www.JazzPharmaceuticals.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements, including, but not limited to, statements related to the anticipated regulatory approval and planned commercial launch of LUVOX CR and the continued development of Jazz Pharmaceuticals' product candidates. These forward-looking statements are based on the company's current expectations and inherently involve significant risks and uncertainties. Jazz Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward looking statements as a result of these risks and uncertainties, which include, without limitation, the risk that the FDA may not approve LUVOX CR for marketing in the United States; risks related to the launch of LUVOX CR; risks related to the development of Jazz Pharmaceuticals' product candidates, including the risk that study or clinical trial results may require Jazz Pharmaceuticals to discontinue the development of one or more product candidates; and risks related to the uncertain and time-consuming regulatory approval process. These and other risk factors are discussed under "Risk Factors" in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2007 filed by Jazz Pharmaceuticals with the Securities and Exchange Commission on November 9, 2007. Jazz Pharmaceuticals undertakes no duty or obligati
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
2. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
3. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
4. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
5. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
6. NPS Pharmaceuticals, Inc. Announces an Increase in Tender Offer Price for Its 3.0% Convertible Notes Due 2008 and Extends Expiration Date Until October 17, 2007
7. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
8. Jazz Pharmaceuticals, Inc. Announces Changes to its Board of Directors
9. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
11. Jazz Pharmaceuticals, Inc. to Announce Third Quarter 2007 Financial Results on November 6, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (T...") today announced updated results from a Phase II... sarcomas metastatic to the lung in a poster prese...ogy Society Meeting held in Miami Beach, Florida, ... entitled "A Phase II Study of Intravenous REOLYSI...
(Date:11/5/2009)..., Nov. 5 The endangered black-foot...n U.S. This rare carnivore feeds on prairie dogs.... and often entire population die-offs in towns occ...s implemented a ferret breeding program and has be...ormerly native habitat. Unfortunately, plague can...
(Date:11/5/2009)... 5 Transgenomic, Inc. (O... results for the quarter ended September 30, 2009....the tables that follow. ,, Third Quarter 2009 ... or $0.01 per share for the third quarter of 2009 ... share for the third quarter of 2008. ,, Net s...
(Date:11/5/2009)...Nov. 5 WaferGen Biosyste...eloper of state-of-the-art genetic analysis system...as joined the company,s Scientific Advisory Board....mercializing novel molecular diagnostics for cance...elopment of computational biology systems for seve...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4
... Borer Technology Offers Greater Control of Common...or Southern U.S. Growers, ST. LOUIS, July 24 The...s deregulated MON 89034, a new insect,protection t...mercially, this,new above ground insect control te...ound and Roundup Ready technologies to be sold as ...
...ly 24 United,Therapeutics Corporation (Nasdaq: U...8 second quarter financial results before the open...erapeutics will host a half-hour teleconference on.... The teleconference is accessible,by dialing 1-80...06-679-8129. A rebroadcast of the teleconference w...
...4 Human Genome,Sciences, Inc. (Nasdaq: HGSI ) to...ointed to the HGS Board of Directors. He will also...e. Until recently, Mr. Southwell was,at Sepracor, ...re he served,as Executive Vice President and Chief...r Corporate Planning, Development and Licensing., ...
Other Biology Technology:New Insect Protection Technology From Monsanto Company Deregulated by USDA 2New Insect Protection Technology From Monsanto Company Deregulated by USDA 3Human Genome Sciences Appoints David P. Southwell to its Board of Directors 2Human Genome Sciences Appoints David P. Southwell to its Board of Directors 3Human Genome Sciences Appoints David P. Southwell to its Board of Directors 4
(Date:11/4/2009)...19 Spectros, developer and manufac...vices which shed light on life-threatening disease...stribution deals for both its T-Stat® VLS Tis...lude Australia, New Zealand, The Netherlands, Bel...e, Spain, Portugal, Poland, Greece, Turkey, and Ru...
(Date:11/4/2009)...ire/ -- What,s the cost of saving a teenage life? ...ting from prescription medication abuse, there,s n..., may be unaware that the lock-boxes they,ve insta...ng timebomb of prescription drugs. That,s why MEDN...al supplies, has formed an exclusive partnership w...
(Date:11/4/2009)... the University of North Carolina at Chapel Hill S..., San Francisco have developed and experimentally ...for existing drugs. , The researchers developed ...he structures of all known drugs are to the natura... -- of disease targets within the cell. In a study...
Breaking Biology News(10 mins):Spectros Signs New International Distribution Deals 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Study points to new uses, unexpected side effects of already existing drugs 2Older patients with dementia at increased risk for flu mortality 60148 1Older patients with dementia at increased risk for flu mortality 60148 2The skeleton 3A Size matters 10538 1The skeleton 3A Size matters 10538 2Global Rainmakers Brings Cutting Edge Biometric Security Products to Reality 10534 1Global Rainmakers Brings Cutting Edge Biometric Security Products to Reality 10534 2Global Rainmakers Brings Cutting Edge Biometric Security Products to Reality 10534 3
..., Pittsburgh, PennsylvaniaResearchers from the Uni... of a newly discovered carnivorous animal, Puiji... a "missing link" in the evolution of the group th.... The analysis of the skeleton and support for the...the Arctic will be described in the April 23 issue...
..., The Rockefeller University and the Institute fo...hed a joint initiative in biology supported by a $... announced today. The initiative, which builds on ...he University, will involve biologists, mathematic... quantitative and theoretical approaches to biolog...
..., , PASADENA, Calif.--Some 25 years after the AIDS...ive vaccine against the human immunodeficiency vir...ctively become stalled. The reason? According to n...lifornia Institute of Technology (Caltech), it,s a...ural HIV antibodies simply don,t have a long enoug...
Other Biology News:Fossil evidence of missing link in the origin of seals, sea lions, walruses found in Canadian Arctic 2$10 million Simons Foundation gift supports new initiative with Institute for Advanced Study 2Caltech scientists show why anti-HIV antibodies are ineffective at blocking infection 2Caltech scientists show why anti-HIV antibodies are ineffective at blocking infection 3
...K (c-Jun NH2-terminal kinase) signal transduction ...ways in mammals. JNK pathway activation occurs in ...th the nuclear accumulation of JNK itself, and is ...eration, oncogenic transformation, morphogenesis, ...
...oteomeLab PF 2D is an automated, two-dimensional f...f complex protein mixtures. Part of Beckman Coult...uces results in just hours. The system effectivel...ll lysates, addressing a key challenge in todays p...
...oteomeLab PA 800 is an automated, high-resolution ... ProteomeLab family of products, the PA 800 offers...terization solutions including molecular weight de..., carbohydrate profiling and mechanisms to study p...
...pid-Screen cDNA Library Panels were designed for f...s of PCRs to identify the desired cDNA clone. The ...er Plate," where each well contains plasmid DNA fr...ll(s) by gel electrophoresis of the reaction produ...
Biology Products: